Nicotinamide Mononucleotide Market
Nicotinamide Mononucleotide Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Nicotinamide Mononucleotide Market Size and Growth
The Nicotinamide Mononucleotide market is experiencing robust growth, driven by rising consumer awareness of anti-aging benefits and increased investment in research. The market size is projected to reach approximately $1.1 billion by 2028, reflecting a compound annual growth rate (CAGR) of around 15% over the next five years. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ GeneHarbor
◍ Herbalmax
◍ Genex Formulas
◍ Shinkowa Pharmaceutical
◍ Maac10 Formulas
◍ Bontac
The Nicotinamide Mononucleotide market features companies like GeneHarbor, Herbalmax, and Shinkowa Pharmaceutical, which focus on health supplements and pharmaceutical products. They innovate formulations and expand distribution, driving market growth. Sales revenues include:
- GeneHarbor: $10 million
- Shinkowa Pharmaceutical: $25 million
- Bontac: $5 million.
◍ Shandong Sihuan Pharmaceutical Co.,Ltd.
◍ EffePharm
◍ Zhejiang Jiahua Pharmchemical Co., Ltd.
Request Sample Report
Market Segmentation
By Application
Health care products
Cosmetics
Request Sample Report
By Product
Content Below 98%
Content Above 98%
Market Growth
Request Sample Report
$ X Billion USD
